1. Camellia sinesis extract associated with liver toxicity

   News item 16 June 2018 Pages: 1 - 1

2. FDA action against unapproved opioid marketing

   News item 16 June 2018 Pages: 2 - 2

3. Ireland's HPRA issues CV safety advice for clarithromycin

   News item 16 June 2018 Pages: 3 - 3

4. Japan's PMDA investigation results: June 2018

   News item 16 June 2018 Pages: 4 - 4

5. New measures to minimise serious liver injury with ulipristal

   News item 16 June 2018 Pages: 5 - 5

6. Risk of birth defects with dolutegravir: new study findings

   News item 16 June 2018 Pages: 6 - 6

7. Six CPM updates featured by Health Canada

   News item 16 June 2018 Pages: 7 - 7

8. Voluntary US recall of naloxone product with Carpuject syringe

   News item 16 June 2018 Pages: 8 - 8

9. Adverse drug reactions to targeted oncological drugs

   Clinical study 16 June 2018 Pages: 9 - 9

10. Cardiac toxicity with chloroquine or hydroxychloroquine

    Clinical study 16 June 2018 Pages: 10 - 10

11. Modified Naranjo scale assessment of adverse reaction causality

    Clinical study 16 June 2018 Pages: 11 - 11

12. No increased risk of ACS with ibuprofen vs paracetamol

    Clinical study 16 June 2018 Pages: 12 - 12

13. Safety of DTaP vaccines in children

    Clinical study 16 June 2018 Pages: 13 - 13

14. Aciclovir

    Case report 16 June 2018 Pages: 14 - 14

15. Acitretin

    Case report 16 June 2018 Pages: 15 - 15

16. Adalimumab

    Case report 16 June 2018 Pages: 16 - 16

17. Adalimumab

    Case report 16 June 2018 Pages: 17 - 17

18. Adalimumab

    Case report 16 June 2018 Pages: 18 - 18

19. Adalimumab

    Case report 16 June 2018 Pages: 19 - 19

20. Adalimumab

    Case report 16 June 2018 Pages: 20 - 20

21. Adalimumab

    Case report 16 June 2018 Pages: 21 - 21

22. Adalimumab/methotrexate

    Case report 16 June 2018 Pages: 22 - 22

23. Adenovirus-vaccine/crs-207

    Case report 16 June 2018 Pages: 23 - 23

24. Alectinib

    Case report 16 June 2018 Pages: 24 - 24

25. Alemtuzumab

    Case report 16 June 2018 Pages: 25 - 25

26. Alemtuzumab

    Case report 16 June 2018 Pages: 26 - 26

27. Alemtuzumab

    Case report 16 June 2018 Pages: 27 - 27

28. Alemtuzumab/antithymocyte-globulin

    Case report 16 June 2018 Pages: 28 - 28

29. Alendronic acid

    Case report 16 June 2018 Pages: 29 - 29

30. Alendronic acid/unspecified glucocorticoids

    Case report 16 June 2018 Pages: 30 - 30

31. Alendronic-acid

    Case report 16 June 2018 Pages: 31 - 31

32. Alendronic-acid

    Case report 16 June 2018 Pages: 32 - 32

33. Alfacalcidol/prednisolone

    Case report 16 June 2018 Pages: 33 - 33

34. Alprazolam abuse/withdrawal

    Case report 16 June 2018 Pages: 34 - 34

35. Alteplase/heparin

    Case report 16 June 2018 Pages: 35 - 35

36. Amantadine

    Case report 16 June 2018 Pages: 36 - 36

37. Amiodarone

    Case report 16 June 2018 Pages: 37 - 37

38. Amiodarone

    Case report 16 June 2018 Pages: 38 - 38

39. Amitriptyline/duloxetine

    Case report 16 June 2018 Pages: 39 - 39

40. Amitriptyline/quetiapine

    Case report 16 June 2018 Pages: 40 - 40

41. Amoxicillin

    Case report 16 June 2018 Pages: 41 - 41

42. Amoxicillin/clavulanic acid

    Case report 16 June 2018 Pages: 42 - 42

43. Ampicillin/sulbactam

    Case report 16 June 2018 Pages: 43 - 43

44. Anabolic steroids/caffeine/ephedrine

    Case report 16 June 2018 Pages: 44 - 44

45. Anaesthetics/Analgesics

    Case report 16 June 2018 Pages: 45 - 45

46. Anagrelide

    Case report 16 June 2018 Pages: 46 - 46

47. Antibacterials

    Case report 16 June 2018 Pages: 47 - 47

48. Antineoplastics

    Case report 16 June 2018 Pages: 48 - 48

49. Antineoplastics

    Case report 16 June 2018 Pages: 49 - 49

50. Antineoplastics

    Case report 16 June 2018 Pages: 50 - 50